The purpose of this session is to give potential applicants to the Commercialization Peer Review Committee of the CIHR Project Grant program (CMZ) an opportunity to hear first-hand about the committee ‘culture’: what aspects are generally well-received by reviewers in CMZ, what factors are considered more important than others, how the committee’s mandate is interpreted, what types of proposals are transferred to or from other committees. Dr. Kathleen Marsman from Borden Ladner Gervais LLP is the current Chair of CMZ and will be available to make comments on these issues and to interact with potential applicants on their questions.
Kathleen Marsman, PhD, is a registered Canadian and U.S. Patent Agent and a Senior Associate at Borden Ladner Gervais LLP. She specializes in patent applications for the life sciences, biotechnology, nutrition and chemistry sectors. She counsels patent applicants on matters of patentability, filing strategy and portfolio management. Her clients include universities, healthcare institutions, start-ups and multinational pharmaceutical and consumer product companies. Learn more about her expertise.